Status:
COMPLETED
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
Lead Sponsor:
AstraZeneca
Conditions:
Hyperlipidemia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor) atorvastatin on urinary protein excretion over 1 year in non-diabetes with moderate proteinuria and hyperch...
Eligibility Criteria
Inclusion
- greater than or equal to 18 years of age
- Hyperlipidemia
- Urinary protein
Exclusion
- Previous rosuvastatin treatment \< 6 months prior to Visit 1
- Statin intolerance
- Severe hypertension
- Diabetes
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
237 Patients enrolled
Trial Details
Trial ID
NCT00296400
Start Date
February 1 2006
End Date
June 1 2009
Last Update
June 16 2011
Active Locations (107)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Avondale, Arizona, United States
2
Research Site
Phoenix, Arizona, United States
3
Research Site
Pasadena, California, United States
4
Research Site
Riverside, California, United States